Enterprise Dynamic
On September 7, 2024, Thailand Miska Bay Health Group (hereinafter referred to as "Miska Bay Group") and Sichuan Jiuzhang Biological Science and Technology Co.,Ltd (hereinafter referred to as " Jiuzhang Bio") h...
[View details]
Rationale: Inducing cancer differentiation is a promising approach to treat cancer. Here, we identified chlorogenic acid (CA), a potential differentiation inducer, for cancer therapy, and elucidated the molecul...
[View details]
Glioblastoma is an aggressive tumor that is associated with distinctive infiltrating microglia/macrophages populations. Previous studies demonstrated that chlorogenic acid (5-caffeoylquinic acid, CHA), a phenol...
[View details]
Developing a photo-affinity probe PAL-CGA revealed ACAT1 as CGA’s key target,and demonstrated CGA inhibits cancer proliferation by blocking ACAT1’s Y407 phosphorylation, highlighting its clinical potential in c...
[View details]
